NCT06885710View on ClinicalTrials.gov

HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients

PHASE1RecruitingINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2028

Conditions
Chronic Hepatitis b
Interventions
BIOLOGICAL

LioCyx-M

Each patient will receive LioCyx-M infusion every one or two weeks, while continuing their existing nucleos(t)ide analog treatment.

Trial Locations (1)

Unknown

RECRUITING

Changhai Hospital, Shanghai

All Listed Sponsors
collaborator

Guangzhou Lion TCR Co Ltd

UNKNOWN

lead

Changhai Hospital

OTHER